Clarithromycin

Back to search

Molecule Structure

Scientific Name

Clarithromycin

Description of the Drug

Clarithromycin is a macrolide antibiotic used for the treatment of a wide variety of bacterial infections such as acute otitis, pharyngitis, tonsillitis, respiratory tract infections, uncomplicated skin infections, and helicobacter pylori infection.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01211

Brand Name(s)

Biaxin, Biaxin xl, Biaxin Xl Pac, Clarie xl, Clarithromycin, Clarithromycin Extended Release, Clarosip, Febzin xl, Klaricid, Klaricid 500, Klaricid adult, Klaricid i.v., Klaricid paed, Klaricid xl, Mycifor xl, Xetinin xl, Zeclar

Company Owner(s)

Nostrum Laboratories Inc, Abbvie Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Lupin Ltd, Sun Pharmaceutical Industries Ltd, Mayne Pharma Llc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Rising Pharma Holdings Inc, Sandoz Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial 70S ribosome PROTEIN NUCLEIC-ACID COMPLEX INHIBITOR CHEMBL2363135

Unichem Links

SureChEMBL SCHEMBL38125
PharmGKB PA449028
Human Metabolome Database HMDB0015342
DrugBank DB01211
PubChem: Thomson Pharma 14913515 14937909
PubChem 84029
Mcule MCULE-7168853332
LINCS LSM-5606
Nikkaji J134.033F
PDBe CTY
BindingDB 50404044
EPA CompTox Dashboard DTXSID3022829
LipidMaps LMPK04000014
DrugCentral 668
Brenda 229298 22099 229297
ChemicalBook CB2225614
Guide to Pharmacology 10903
GSRS 31dbbf15-4c12-4ff3-a404-068c5772ddc5
rxnorm CLARITHROMYCIN BIAXIN
PubChem: Drugs of the Future 12013874
KEGG Ligand C06912
ChEBI 3732
NIH Clinical Collection SAM001246748
ZINC ZINC000085534098